Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence Article Swipe
Mohamed Kadry Taher
,
Talia Salzman
,
Allyson Banal
,
Kate Morissette
,
Francesca Reyes Domingo
,
Angela M. Cheung
,
Curtis Cooper
,
Laura Boland
,
Alexandra M.E. Zuckermann
,
Muhammad Abu Shadeque Mullah
,
Claudie Laprise
,
Roberto Colonna
,
Ayan Hashi
,
Prinon Rahman
,
Erin Collins
,
Tricia Corrin
,
Lisa Waddell
,
Jason E. Pagaduan
,
Rukshanda Ahmad
,
Alejandra García
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.24095/hpcdp.45.3.02
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.24095/hpcdp.45.3.02
Introduction We investigated the prevalence of new or persistent manifestations experienced by COVID-19 survivors at 3 or more months after their initial infection, collectively known as post-COVID-19 condition (PCC). Methods We searched four electronic databases and major grey literature resources for prospective studies, systematic reviews, authoritative reports and population surveys. A random-effects meta-analysis pooled the prevalence data of 22 symptoms and outcomes. The GRADE approach was used to assess the certainty of evidence. PROSPERO CRD42021231476. Results Of 20 731 identified references, 194 met our inclusion criteria. These studies followed 483 531 individuals with confirmed COVID-19 diagnosis over periods of up to 2 years. Most focused on adults, nearly two-thirds were conducted in Europe and 63% were of high or moderate quality. The supplementary search identified 17 systematic reviews, five authoritative reports and four population surveys that reported on PCC prevalence. Our analysis revealed that more than half of COVID-19 survivors experienced one or more symptoms more than a year after their initial infection. The most common symptoms were fatiguedyspneamemory, sleep or concentration disturbances; depressionand pain. Limitation in returning to work was the most common outcome. Prevalence tended to be higher among females, individuals hospitalized during their initial infection and those who experienced severe COVID-19 illness. Conclusion PCC presents a significant health burden, affecting some groups more than others. This information will help inform health care system policies and services for people living with PCC and those caring for them.
Related Topics
Concepts
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.24095/hpcdp.45.3.02
- OA Status
- diamond
- Cited By
- 9
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4408334733
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4408334733Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.24095/hpcdp.45.3.02Digital Object Identifier
- Title
-
Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidenceWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-03-01Full publication date if available
- Authors
-
Mohamed Kadry Taher, Talia Salzman, Allyson Banal, Kate Morissette, Francesca Reyes Domingo, Angela M. Cheung, Curtis Cooper, Laura Boland, Alexandra M.E. Zuckermann, Muhammad Abu Shadeque Mullah, Claudie Laprise, Roberto Colonna, Ayan Hashi, Prinon Rahman, Erin Collins, Tricia Corrin, Lisa Waddell, Jason E. Pagaduan, Rukshanda Ahmad, Alejandra GarcíaList of authors in order
- Landing page
-
https://doi.org/10.24095/hpcdp.45.3.02Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.24095/hpcdp.45.3.02Direct OA link when available
- Concepts
-
Meta-analysis, Medicine, Systematic review, Population, MEDLINE, Coronavirus disease 2019 (COVID-19), Family medicine, Demography, Pediatrics, Environmental health, Internal medicine, Disease, Political science, Sociology, Law, Infectious disease (medical specialty)Top concepts (fields/topics) attached by OpenAlex
- Cited by
-
9Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 9Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4408334733 |
|---|---|
| doi | https://doi.org/10.24095/hpcdp.45.3.02 |
| ids.doi | https://doi.org/10.24095/hpcdp.45.3.02 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40073162 |
| ids.openalex | https://openalex.org/W4408334733 |
| fwci | 40.96954333 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000453 |
| mesh[1].descriptor_ui | D000086382 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | epidemiology |
| mesh[1].descriptor_name | COVID-19 |
| mesh[2].qualifier_ui | Q000150 |
| mesh[2].descriptor_ui | D000086382 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | complications |
| mesh[2].descriptor_name | COVID-19 |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D015995 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Prevalence |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D011446 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Prospective Studies |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D000086402 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | SARS-CoV-2 |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D014943 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Global Health |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D005260 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Female |
| mesh[8].qualifier_ui | Q000706 |
| mesh[8].descriptor_ui | D017741 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | statistics & numerical data |
| mesh[8].descriptor_name | Survivors |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000094024 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Post-Acute COVID-19 Syndrome |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | Q000453 |
| mesh[11].descriptor_ui | D000086382 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | epidemiology |
| mesh[11].descriptor_name | COVID-19 |
| mesh[12].qualifier_ui | Q000150 |
| mesh[12].descriptor_ui | D000086382 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | complications |
| mesh[12].descriptor_name | COVID-19 |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D015995 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Prevalence |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D011446 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Prospective Studies |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D000086402 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | SARS-CoV-2 |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D014943 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Global Health |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D005260 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Female |
| mesh[18].qualifier_ui | Q000706 |
| mesh[18].descriptor_ui | D017741 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | statistics & numerical data |
| mesh[18].descriptor_name | Survivors |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D000094024 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Post-Acute COVID-19 Syndrome |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D006801 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Humans |
| mesh[21].qualifier_ui | Q000453 |
| mesh[21].descriptor_ui | D000086382 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | epidemiology |
| mesh[21].descriptor_name | COVID-19 |
| mesh[22].qualifier_ui | Q000150 |
| mesh[22].descriptor_ui | D000086382 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | complications |
| mesh[22].descriptor_name | COVID-19 |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D015995 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Prevalence |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D011446 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Prospective Studies |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D000086402 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | SARS-CoV-2 |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D014943 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Global Health |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D005260 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Female |
| mesh[28].qualifier_ui | Q000706 |
| mesh[28].descriptor_ui | D017741 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | statistics & numerical data |
| mesh[28].descriptor_name | Survivors |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D000094024 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Post-Acute COVID-19 Syndrome |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D006801 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Humans |
| mesh[31].qualifier_ui | Q000453 |
| mesh[31].descriptor_ui | D000086382 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | epidemiology |
| mesh[31].descriptor_name | COVID-19 |
| mesh[32].qualifier_ui | Q000150 |
| mesh[32].descriptor_ui | D000086382 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | complications |
| mesh[32].descriptor_name | COVID-19 |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D015995 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Prevalence |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D011446 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Prospective Studies |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D000086402 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | SARS-CoV-2 |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D014943 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Global Health |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D005260 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Female |
| mesh[38].qualifier_ui | Q000706 |
| mesh[38].descriptor_ui | D017741 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | statistics & numerical data |
| mesh[38].descriptor_name | Survivors |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D000094024 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Post-Acute COVID-19 Syndrome |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D006801 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Humans |
| mesh[41].qualifier_ui | Q000453 |
| mesh[41].descriptor_ui | D000086382 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | epidemiology |
| mesh[41].descriptor_name | COVID-19 |
| mesh[42].qualifier_ui | Q000150 |
| mesh[42].descriptor_ui | D000086382 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | complications |
| mesh[42].descriptor_name | COVID-19 |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D015995 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Prevalence |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D011446 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Prospective Studies |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D000086402 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | SARS-CoV-2 |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D014943 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Global Health |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D005260 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Female |
| mesh[48].qualifier_ui | Q000706 |
| mesh[48].descriptor_ui | D017741 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | statistics & numerical data |
| mesh[48].descriptor_name | Survivors |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D000094024 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Post-Acute COVID-19 Syndrome |
| type | review |
| title | Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence |
| biblio.issue | 3 |
| biblio.volume | 45 |
| biblio.last_page | 138 |
| biblio.first_page | 112 |
| topics[0].id | https://openalex.org/T11368 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9943000078201294 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2728 |
| topics[0].subfield.display_name | Neurology |
| topics[0].display_name | Long-Term Effects of COVID-19 |
| topics[1].id | https://openalex.org/T11282 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9229000210762024 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2738 |
| topics[1].subfield.display_name | Psychiatry and Mental health |
| topics[1].display_name | Fibromyalgia and Chronic Fatigue Syndrome Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C95190672 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7733964323997498 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q815382 |
| concepts[0].display_name | Meta-analysis |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6894406080245972 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C189708586 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5721574425697327 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1504425 |
| concepts[2].display_name | Systematic review |
| concepts[3].id | https://openalex.org/C2908647359 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5340109467506409 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[3].display_name | Population |
| concepts[4].id | https://openalex.org/C2779473830 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5178059339523315 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1540899 |
| concepts[4].display_name | MEDLINE |
| concepts[5].id | https://openalex.org/C3008058167 |
| concepts[5].level | 4 |
| concepts[5].score | 0.48508942127227783 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[5].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[6].id | https://openalex.org/C512399662 |
| concepts[6].level | 1 |
| concepts[6].score | 0.42821332812309265 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[6].display_name | Family medicine |
| concepts[7].id | https://openalex.org/C149923435 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4208187758922577 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q37732 |
| concepts[7].display_name | Demography |
| concepts[8].id | https://openalex.org/C187212893 |
| concepts[8].level | 1 |
| concepts[8].score | 0.32938268780708313 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[8].display_name | Pediatrics |
| concepts[9].id | https://openalex.org/C99454951 |
| concepts[9].level | 1 |
| concepts[9].score | 0.22610622644424438 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[9].display_name | Environmental health |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.14715999364852905 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C2779134260 |
| concepts[11].level | 2 |
| concepts[11].score | 0.08010688424110413 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[11].display_name | Disease |
| concepts[12].id | https://openalex.org/C17744445 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[12].display_name | Political science |
| concepts[13].id | https://openalex.org/C144024400 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q21201 |
| concepts[13].display_name | Sociology |
| concepts[14].id | https://openalex.org/C199539241 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[14].display_name | Law |
| concepts[15].id | https://openalex.org/C524204448 |
| concepts[15].level | 3 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[15].display_name | Infectious disease (medical specialty) |
| keywords[0].id | https://openalex.org/keywords/meta-analysis |
| keywords[0].score | 0.7733964323997498 |
| keywords[0].display_name | Meta-analysis |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6894406080245972 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/systematic-review |
| keywords[2].score | 0.5721574425697327 |
| keywords[2].display_name | Systematic review |
| keywords[3].id | https://openalex.org/keywords/population |
| keywords[3].score | 0.5340109467506409 |
| keywords[3].display_name | Population |
| keywords[4].id | https://openalex.org/keywords/medline |
| keywords[4].score | 0.5178059339523315 |
| keywords[4].display_name | MEDLINE |
| keywords[5].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[5].score | 0.48508942127227783 |
| keywords[5].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[6].id | https://openalex.org/keywords/family-medicine |
| keywords[6].score | 0.42821332812309265 |
| keywords[6].display_name | Family medicine |
| keywords[7].id | https://openalex.org/keywords/demography |
| keywords[7].score | 0.4208187758922577 |
| keywords[7].display_name | Demography |
| keywords[8].id | https://openalex.org/keywords/pediatrics |
| keywords[8].score | 0.32938268780708313 |
| keywords[8].display_name | Pediatrics |
| keywords[9].id | https://openalex.org/keywords/environmental-health |
| keywords[9].score | 0.22610622644424438 |
| keywords[9].display_name | Environmental health |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.14715999364852905 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/disease |
| keywords[11].score | 0.08010688424110413 |
| keywords[11].display_name | Disease |
| language | en |
| locations[0].id | doi:10.24095/hpcdp.45.3.02 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210189458 |
| locations[0].source.issn | 2368-738X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2368-738X |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Health Promotion and Chronic Disease Prevention in Canada |
| locations[0].source.host_organization | https://openalex.org/P4310312987 |
| locations[0].source.host_organization_name | Public Health Agency of Canada |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310312987, https://openalex.org/P4310312968 |
| locations[0].source.host_organization_lineage_names | Public Health Agency of Canada, Health Canada |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Health Promotion and Chronic Disease Prevention in Canada |
| locations[0].landing_page_url | https://doi.org/10.24095/hpcdp.45.3.02 |
| locations[1].id | pmid:40073162 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Health promotion and chronic disease prevention in Canada : research, policy and practice |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40073162 |
| locations[2].id | pmh:oai:doaj.org/article:93dc0f6173304ed08cc6392be8c31fcf |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Health Promotion and Chronic Disease Prevention in Canada, Vol 45, Iss 3, Pp 112-138 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/93dc0f6173304ed08cc6392be8c31fcf |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:12039764 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | cc-by |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/cc-by |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Health Promot Chronic Dis Prev Can |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12039764 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5056187674 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5754-7512 |
| authorships[0].author.display_name | Mohamed Kadry Taher |
| authorships[0].countries | CA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I153718931 |
| authorships[0].affiliations[0].raw_affiliation_string | School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I177235860 |
| authorships[0].affiliations[1].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[0].institutions[0].id | https://openalex.org/I177235860 |
| authorships[0].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[0].institutions[0].type | government |
| authorships[0].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[0].institutions[0].country_code | CA |
| authorships[0].institutions[0].display_name | Public Health Agency of Canada |
| authorships[0].institutions[1].id | https://openalex.org/I153718931 |
| authorships[0].institutions[1].ror | https://ror.org/03c4mmv16 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I153718931 |
| authorships[0].institutions[1].country_code | CA |
| authorships[0].institutions[1].display_name | University of Ottawa |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mohamed Kadry Taher |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada |
| authorships[1].author.id | https://openalex.org/A5000848068 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2286-055X |
| authorships[1].author.display_name | Talia Salzman |
| authorships[1].countries | CA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[1].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[1].institutions[0].id | https://openalex.org/I177235860 |
| authorships[1].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[1].institutions[0].country_code | CA |
| authorships[1].institutions[0].display_name | Public Health Agency of Canada |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Talia Salzman |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[2].author.id | https://openalex.org/A5116588248 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Allyson Banal |
| authorships[2].countries | CA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[2].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[2].institutions[0].id | https://openalex.org/I177235860 |
| authorships[2].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[2].institutions[0].country_code | CA |
| authorships[2].institutions[0].display_name | Public Health Agency of Canada |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Allyson Banal |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[3].author.id | https://openalex.org/A5051849998 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Kate Morissette |
| authorships[3].countries | CA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[3].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[3].institutions[0].id | https://openalex.org/I177235860 |
| authorships[3].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[3].institutions[0].country_code | CA |
| authorships[3].institutions[0].display_name | Public Health Agency of Canada |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kate Morissette |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[4].author.id | https://openalex.org/A5039475341 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8813-8279 |
| authorships[4].author.display_name | Francesca Reyes Domingo |
| authorships[4].countries | CA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[4].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[4].institutions[0].id | https://openalex.org/I177235860 |
| authorships[4].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[4].institutions[0].type | government |
| authorships[4].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[4].institutions[0].country_code | CA |
| authorships[4].institutions[0].display_name | Public Health Agency of Canada |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Francesca R. Domingo |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[5].author.id | https://openalex.org/A5022037416 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-8332-0744 |
| authorships[5].author.display_name | Angela M. Cheung |
| authorships[5].countries | CA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2801845744, https://openalex.org/I4388891853 |
| authorships[5].affiliations[0].raw_affiliation_string | Toronto General Hospital Research Institute and Schroeder Arthritis Institute, Toronto, Ontario, Canada |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I1325899441, https://openalex.org/I185261750, https://openalex.org/I4210130843 |
| authorships[5].affiliations[1].raw_affiliation_string | Department of Medicine and Joint Department of Medical Imaging, University Health Network and Sinai Health System, University of Toronto, Toronto, Ontario, Canada |
| authorships[5].institutions[0].id | https://openalex.org/I4388891853 |
| authorships[5].institutions[0].ror | https://ror.org/03ex4ek60 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I1325899441, https://openalex.org/I2799337515, https://openalex.org/I4388446386, https://openalex.org/I4388891853 |
| authorships[5].institutions[0].country_code | |
| authorships[5].institutions[0].display_name | Schroeder Arthritis Institute |
| authorships[5].institutions[1].id | https://openalex.org/I4210130843 |
| authorships[5].institutions[1].ror | https://ror.org/044790d95 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I4210130843 |
| authorships[5].institutions[1].country_code | CA |
| authorships[5].institutions[1].display_name | Sinai Health System |
| authorships[5].institutions[2].id | https://openalex.org/I2801845744 |
| authorships[5].institutions[2].ror | https://ror.org/026pg9j08 |
| authorships[5].institutions[2].type | healthcare |
| authorships[5].institutions[2].lineage | https://openalex.org/I1325899441, https://openalex.org/I2801845744 |
| authorships[5].institutions[2].country_code | CA |
| authorships[5].institutions[2].display_name | Toronto General Hospital |
| authorships[5].institutions[3].id | https://openalex.org/I1325899441 |
| authorships[5].institutions[3].ror | https://ror.org/042xt5161 |
| authorships[5].institutions[3].type | healthcare |
| authorships[5].institutions[3].lineage | https://openalex.org/I1325899441 |
| authorships[5].institutions[3].country_code | CA |
| authorships[5].institutions[3].display_name | University Health Network |
| authorships[5].institutions[4].id | https://openalex.org/I185261750 |
| authorships[5].institutions[4].ror | https://ror.org/03dbr7087 |
| authorships[5].institutions[4].type | education |
| authorships[5].institutions[4].lineage | https://openalex.org/I185261750 |
| authorships[5].institutions[4].country_code | CA |
| authorships[5].institutions[4].display_name | University of Toronto |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Angela M. Cheung |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Medicine and Joint Department of Medical Imaging, University Health Network and Sinai Health System, University of Toronto, Toronto, Ontario, Canada, Toronto General Hospital Research Institute and Schroeder Arthritis Institute, Toronto, Ontario, Canada |
| authorships[6].author.id | https://openalex.org/A5009499168 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3368-3499 |
| authorships[6].author.display_name | Curtis Cooper |
| authorships[6].countries | CA |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I153718931, https://openalex.org/I2800722420 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Medicine, University of OttawaOttawa Hospital Research Institute, Ottawa, Ontario, Canada |
| authorships[6].institutions[0].id | https://openalex.org/I2800722420 |
| authorships[6].institutions[0].ror | https://ror.org/03c62dg59 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2800722420 |
| authorships[6].institutions[0].country_code | CA |
| authorships[6].institutions[0].display_name | Ottawa Hospital |
| authorships[6].institutions[1].id | https://openalex.org/I153718931 |
| authorships[6].institutions[1].ror | https://ror.org/03c4mmv16 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I153718931 |
| authorships[6].institutions[1].country_code | CA |
| authorships[6].institutions[1].display_name | University of Ottawa |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Curtis L. Cooper |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Medicine, University of OttawaOttawa Hospital Research Institute, Ottawa, Ontario, Canada |
| authorships[7].author.id | https://openalex.org/A5014624332 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-8680-9844 |
| authorships[7].author.display_name | Laura Boland |
| authorships[7].countries | CA |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[7].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[7].institutions[0].id | https://openalex.org/I177235860 |
| authorships[7].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[7].institutions[0].type | government |
| authorships[7].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[7].institutions[0].country_code | CA |
| authorships[7].institutions[0].display_name | Public Health Agency of Canada |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Laura Boland |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[8].author.id | https://openalex.org/A5058136099 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-0242-8815 |
| authorships[8].author.display_name | Alexandra M.E. Zuckermann |
| authorships[8].countries | CA |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[8].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[8].institutions[0].id | https://openalex.org/I177235860 |
| authorships[8].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[8].institutions[0].country_code | CA |
| authorships[8].institutions[0].display_name | Public Health Agency of Canada |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Alexandra M. Zuckermann |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[9].author.id | https://openalex.org/A5050793586 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Muhammad Abu Shadeque Mullah |
| authorships[9].countries | CA |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[9].affiliations[0].raw_affiliation_string | Infectious Disease and Vaccination Programs Branch, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[9].institutions[0].id | https://openalex.org/I177235860 |
| authorships[9].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[9].institutions[0].type | government |
| authorships[9].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[9].institutions[0].country_code | CA |
| authorships[9].institutions[0].display_name | Public Health Agency of Canada |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Muhammad A. Mullah |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Infectious Disease and Vaccination Programs Branch, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[10].author.id | https://openalex.org/A5003620825 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Claudie Laprise |
| authorships[10].countries | CA |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, Quebec, Canada |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I177235860 |
| authorships[10].affiliations[1].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[10].institutions[0].id | https://openalex.org/I177235860 |
| authorships[10].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[10].institutions[0].type | government |
| authorships[10].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[10].institutions[0].country_code | CA |
| authorships[10].institutions[0].display_name | Public Health Agency of Canada |
| authorships[10].institutions[1].id | https://openalex.org/I70931966 |
| authorships[10].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[10].institutions[1].country_code | CA |
| authorships[10].institutions[1].display_name | Université de Montréal |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Claudie Laprise |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, Quebec, Canada, Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[11].author.id | https://openalex.org/A5088127962 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-8274-4809 |
| authorships[11].author.display_name | Roberto Colonna |
| authorships[11].countries | CA |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[11].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[11].institutions[0].id | https://openalex.org/I177235860 |
| authorships[11].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[11].institutions[0].type | government |
| authorships[11].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[11].institutions[0].country_code | CA |
| authorships[11].institutions[0].display_name | Public Health Agency of Canada |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Roberto Colonna |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[12].author.id | https://openalex.org/A5074499642 |
| authorships[12].author.orcid | https://orcid.org/0009-0006-5814-9213 |
| authorships[12].author.display_name | Ayan Hashi |
| authorships[12].countries | CA |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[12].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[12].institutions[0].id | https://openalex.org/I177235860 |
| authorships[12].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[12].institutions[0].type | government |
| authorships[12].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[12].institutions[0].country_code | CA |
| authorships[12].institutions[0].display_name | Public Health Agency of Canada |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Ayan Hashi |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[13].author.id | https://openalex.org/A5034071047 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Prinon Rahman |
| authorships[13].countries | CA |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[13].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[13].institutions[0].id | https://openalex.org/I177235860 |
| authorships[13].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[13].institutions[0].type | government |
| authorships[13].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[13].institutions[0].country_code | CA |
| authorships[13].institutions[0].display_name | Public Health Agency of Canada |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Prinon Rahman |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[14].author.id | https://openalex.org/A5025267854 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Erin Collins |
| authorships[14].countries | CA |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[14].affiliations[0].raw_affiliation_string | Population Health Modelling Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario,Canada |
| authorships[14].institutions[0].id | https://openalex.org/I177235860 |
| authorships[14].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[14].institutions[0].type | government |
| authorships[14].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[14].institutions[0].country_code | CA |
| authorships[14].institutions[0].display_name | Public Health Agency of Canada |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Erin Collins |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Population Health Modelling Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario,Canada |
| authorships[15].author.id | https://openalex.org/A5010193819 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-5514-1589 |
| authorships[15].author.display_name | Tricia Corrin |
| authorships[15].countries | CA |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[15].affiliations[0].raw_affiliation_string | Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada |
| authorships[15].institutions[0].id | https://openalex.org/I177235860 |
| authorships[15].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[15].institutions[0].type | government |
| authorships[15].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[15].institutions[0].country_code | CA |
| authorships[15].institutions[0].display_name | Public Health Agency of Canada |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Tricia Corrin |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada |
| authorships[16].author.id | https://openalex.org/A5066379363 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-4887-5124 |
| authorships[16].author.display_name | Lisa Waddell |
| authorships[16].countries | CA |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[16].affiliations[0].raw_affiliation_string | Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada |
| authorships[16].institutions[0].id | https://openalex.org/I177235860 |
| authorships[16].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[16].institutions[0].type | government |
| authorships[16].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[16].institutions[0].country_code | CA |
| authorships[16].institutions[0].display_name | Public Health Agency of Canada |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Lisa A. Waddell |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, Ontario, Canada |
| authorships[17].author.id | https://openalex.org/A5087166429 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-6046-4267 |
| authorships[17].author.display_name | Jason E. Pagaduan |
| authorships[17].countries | CA |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[17].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[17].institutions[0].id | https://openalex.org/I177235860 |
| authorships[17].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[17].institutions[0].type | government |
| authorships[17].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[17].institutions[0].country_code | CA |
| authorships[17].institutions[0].display_name | Public Health Agency of Canada |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Jason E. Pagaduan |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[18].author.id | https://openalex.org/A5109358186 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Rukshanda Ahmad |
| authorships[18].countries | CA |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[18].affiliations[0].raw_affiliation_string | Risk Assessment Division, Centre for Surveillance, Integrated Insights and Risk Assessment, Data, Surveillance and Foresight Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[18].institutions[0].id | https://openalex.org/I177235860 |
| authorships[18].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[18].institutions[0].type | government |
| authorships[18].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[18].institutions[0].country_code | CA |
| authorships[18].institutions[0].display_name | Public Health Agency of Canada |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Rukshanda Ahmad |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Risk Assessment Division, Centre for Surveillance, Integrated Insights and Risk Assessment, Data, Surveillance and Foresight Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[19].author.id | https://openalex.org/A5101984172 |
| authorships[19].author.orcid | https://orcid.org/0009-0008-9433-9684 |
| authorships[19].author.display_name | Alejandra García |
| authorships[19].countries | CA |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I177235860 |
| authorships[19].affiliations[0].raw_affiliation_string | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| authorships[19].institutions[0].id | https://openalex.org/I177235860 |
| authorships[19].institutions[0].ror | https://ror.org/023xf2a37 |
| authorships[19].institutions[0].type | government |
| authorships[19].institutions[0].lineage | https://openalex.org/I1288894424, https://openalex.org/I177235860 |
| authorships[19].institutions[0].country_code | CA |
| authorships[19].institutions[0].display_name | Public Health Agency of Canada |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | Alejandra P. Jaramillo Garcia |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.24095/hpcdp.45.3.02 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Global prevalence of post-COVID-19 condition: a systematic review and meta-analysis of prospective evidence |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11368 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9943000078201294 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2728 |
| primary_topic.subfield.display_name | Neurology |
| primary_topic.display_name | Long-Term Effects of COVID-19 |
| related_works | https://openalex.org/W4205698903, https://openalex.org/W4400613637, https://openalex.org/W4294968941, https://openalex.org/W4283819461, https://openalex.org/W4390279739, https://openalex.org/W4205413867, https://openalex.org/W3179695362, https://openalex.org/W4294636802, https://openalex.org/W2070311887, https://openalex.org/W2115099528 |
| cited_by_count | 9 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 9 |
| locations_count | 4 |
| best_oa_location.id | doi:10.24095/hpcdp.45.3.02 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210189458 |
| best_oa_location.source.issn | 2368-738X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2368-738X |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Health Promotion and Chronic Disease Prevention in Canada |
| best_oa_location.source.host_organization | https://openalex.org/P4310312987 |
| best_oa_location.source.host_organization_name | Public Health Agency of Canada |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310312987, https://openalex.org/P4310312968 |
| best_oa_location.source.host_organization_lineage_names | Public Health Agency of Canada, Health Canada |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Health Promotion and Chronic Disease Prevention in Canada |
| best_oa_location.landing_page_url | https://doi.org/10.24095/hpcdp.45.3.02 |
| primary_location.id | doi:10.24095/hpcdp.45.3.02 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210189458 |
| primary_location.source.issn | 2368-738X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2368-738X |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Health Promotion and Chronic Disease Prevention in Canada |
| primary_location.source.host_organization | https://openalex.org/P4310312987 |
| primary_location.source.host_organization_name | Public Health Agency of Canada |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310312987, https://openalex.org/P4310312968 |
| primary_location.source.host_organization_lineage_names | Public Health Agency of Canada, Health Canada |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Health Promotion and Chronic Disease Prevention in Canada |
| primary_location.landing_page_url | https://doi.org/10.24095/hpcdp.45.3.02 |
| publication_date | 2025-03-01 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.2 | 106 |
| abstract_inverted_index.3 | 16 |
| abstract_inverted_index.A | 53 |
| abstract_inverted_index.a | 162, 215 |
| abstract_inverted_index.17 | 130 |
| abstract_inverted_index.20 | 82 |
| abstract_inverted_index.22 | 61 |
| abstract_inverted_index.Of | 81 |
| abstract_inverted_index.We | 2, 33 |
| abstract_inverted_index.as | 26 |
| abstract_inverted_index.at | 15 |
| abstract_inverted_index.be | 193 |
| abstract_inverted_index.by | 12 |
| abstract_inverted_index.in | 116, 181 |
| abstract_inverted_index.of | 6, 60, 74, 103, 121, 152 |
| abstract_inverted_index.on | 110, 142 |
| abstract_inverted_index.or | 8, 17, 123, 157, 175 |
| abstract_inverted_index.to | 70, 105, 183, 192 |
| abstract_inverted_index.up | 104 |
| abstract_inverted_index.194 | 86 |
| abstract_inverted_index.483 | 94 |
| abstract_inverted_index.531 | 95 |
| abstract_inverted_index.63% | 119 |
| abstract_inverted_index.731 | 83 |
| abstract_inverted_index.Our | 145 |
| abstract_inverted_index.PCC | 143, 213, 240 |
| abstract_inverted_index.The | 65, 126, 168 |
| abstract_inverted_index.and | 38, 50, 63, 118, 136, 203, 234, 241 |
| abstract_inverted_index.for | 43, 236, 244 |
| abstract_inverted_index.met | 87 |
| abstract_inverted_index.new | 7 |
| abstract_inverted_index.one | 156 |
| abstract_inverted_index.our | 88 |
| abstract_inverted_index.the | 4, 57, 72, 186 |
| abstract_inverted_index.was | 68, 185 |
| abstract_inverted_index.who | 205 |
| abstract_inverted_index.Most | 108 |
| abstract_inverted_index.This | 225 |
| abstract_inverted_index.care | 231 |
| abstract_inverted_index.data | 59 |
| abstract_inverted_index.five | 133 |
| abstract_inverted_index.four | 35, 137 |
| abstract_inverted_index.grey | 40 |
| abstract_inverted_index.half | 151 |
| abstract_inverted_index.help | 228 |
| abstract_inverted_index.high | 122 |
| abstract_inverted_index.more | 18, 149, 158, 160, 222 |
| abstract_inverted_index.most | 169, 187 |
| abstract_inverted_index.over | 101 |
| abstract_inverted_index.some | 220 |
| abstract_inverted_index.than | 150, 161, 223 |
| abstract_inverted_index.that | 140, 148 |
| abstract_inverted_index.used | 69 |
| abstract_inverted_index.were | 114, 120, 172 |
| abstract_inverted_index.will | 227 |
| abstract_inverted_index.with | 97, 239 |
| abstract_inverted_index.work | 184 |
| abstract_inverted_index.year | 163 |
| abstract_inverted_index.<sec> | 0, 31, 79, 211 |
| abstract_inverted_index.GRADE | 66 |
| abstract_inverted_index.These | 91 |
| abstract_inverted_index.after | 20, 164 |
| abstract_inverted_index.among | 195 |
| abstract_inverted_index.known | 25 |
| abstract_inverted_index.major | 39 |
| abstract_inverted_index.pain. | 179 |
| abstract_inverted_index.sleep | 174 |
| abstract_inverted_index.their | 21, 165, 200 |
| abstract_inverted_index.them. | 245 |
| abstract_inverted_index.those | 204, 242 |
| abstract_inverted_index.(PCC). | 29 |
| abstract_inverted_index.</sec> | 30, 78, 210, 246 |
| abstract_inverted_index.Europe | 117 |
| abstract_inverted_index.assess | 71 |
| abstract_inverted_index.caring | 243 |
| abstract_inverted_index.common | 170, 188 |
| abstract_inverted_index.during | 199 |
| abstract_inverted_index.groups | 221 |
| abstract_inverted_index.health | 217, 230 |
| abstract_inverted_index.higher | 194 |
| abstract_inverted_index.inform | 229 |
| abstract_inverted_index.living | 238 |
| abstract_inverted_index.months | 19 |
| abstract_inverted_index.nearly | 112 |
| abstract_inverted_index.people | 237 |
| abstract_inverted_index.pooled | 56 |
| abstract_inverted_index.search | 128 |
| abstract_inverted_index.severe | 207 |
| abstract_inverted_index.system | 232 |
| abstract_inverted_index.tended | 191 |
| abstract_inverted_index.years. | 107 |
| abstract_inverted_index.adults, | 111 |
| abstract_inverted_index.burden, | 218 |
| abstract_inverted_index.focused | 109 |
| abstract_inverted_index.initial | 22, 166, 201 |
| abstract_inverted_index.others. | 224 |
| abstract_inverted_index.periods | 102 |
| abstract_inverted_index.reports | 49, 135 |
| abstract_inverted_index.studies | 92 |
| abstract_inverted_index.surveys | 139 |
| abstract_inverted_index.COVID-19 | 13, 99, 153, 208 |
| abstract_inverted_index.PROSPERO | 76 |
| abstract_inverted_index.analysis | 146 |
| abstract_inverted_index.approach | 67 |
| abstract_inverted_index.females, | 196 |
| abstract_inverted_index.followed | 93 |
| abstract_inverted_index.illness. | 209 |
| abstract_inverted_index.moderate | 124 |
| abstract_inverted_index.outcome. | 189 |
| abstract_inverted_index.policies | 233 |
| abstract_inverted_index.presents | 214 |
| abstract_inverted_index.quality. | 125 |
| abstract_inverted_index.reported | 141 |
| abstract_inverted_index.revealed | 147 |
| abstract_inverted_index.reviews, | 47, 132 |
| abstract_inverted_index.searched | 34 |
| abstract_inverted_index.services | 235 |
| abstract_inverted_index.studies, | 45 |
| abstract_inverted_index.surveys. | 52 |
| abstract_inverted_index.symptoms | 62, 159, 171 |
| abstract_inverted_index.affecting | 219 |
| abstract_inverted_index.certainty | 73 |
| abstract_inverted_index.condition | 28 |
| abstract_inverted_index.conducted | 115 |
| abstract_inverted_index.confirmed | 98 |
| abstract_inverted_index.criteria. | 90 |
| abstract_inverted_index.databases | 37 |
| abstract_inverted_index.diagnosis | 100 |
| abstract_inverted_index.evidence. | 75 |
| abstract_inverted_index.inclusion | 89 |
| abstract_inverted_index.infection | 202 |
| abstract_inverted_index.outcomes. | 64 |
| abstract_inverted_index.resources | 42 |
| abstract_inverted_index.returning | 182 |
| abstract_inverted_index.survivors | 14, 154 |
| abstract_inverted_index.Limitation | 180 |
| abstract_inverted_index.Prevalence | 190 |
| abstract_inverted_index.electronic | 36 |
| abstract_inverted_index.identified | 84, 129 |
| abstract_inverted_index.infection, | 23 |
| abstract_inverted_index.infection. | 167 |
| abstract_inverted_index.literature | 41 |
| abstract_inverted_index.persistent | 9 |
| abstract_inverted_index.population | 51, 138 |
| abstract_inverted_index.prevalence | 5, 58 |
| abstract_inverted_index.systematic | 46, 131 |
| abstract_inverted_index.two-thirds | 113 |
| abstract_inverted_index.experienced | 11, 155, 206 |
| abstract_inverted_index.individuals | 96, 197 |
| abstract_inverted_index.information | 226 |
| abstract_inverted_index.prevalence. | 144 |
| abstract_inverted_index.prospective | 44 |
| abstract_inverted_index.references, | 85 |
| abstract_inverted_index.significant | 216 |
| abstract_inverted_index.collectively | 24 |
| abstract_inverted_index.hospitalized | 198 |
| abstract_inverted_index.investigated | 3 |
| abstract_inverted_index.authoritative | 48, 134 |
| abstract_inverted_index.concentration | 176 |
| abstract_inverted_index.depressionand | 178 |
| abstract_inverted_index.disturbances; | 177 |
| abstract_inverted_index.meta-analysis | 55 |
| abstract_inverted_index.post-COVID-19 | 27 |
| abstract_inverted_index.supplementary | 127 |
| abstract_inverted_index.manifestations | 10 |
| abstract_inverted_index.random-effects | 54 |
| abstract_inverted_index.CRD42021231476. | 77 |
| abstract_inverted_index.fatiguedyspneamemory, | 173 |
| abstract_inverted_index.<title>Methods</title> | 32 |
| abstract_inverted_index.<title>Results</title> | 80 |
| abstract_inverted_index.<title>Conclusion</title> | 212 |
| abstract_inverted_index.<title>Introduction</title> | 1 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 20 |
| citation_normalized_percentile.value | 0.995118 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |